Disclosing Genetic Risk of Alzheimer’s Disease to Cognitively Impaired Patients and Visit Companions: Findings from The REVEAL Study

OBJECTIVE: To describe the impact of genetic information on Alzheimer’s disease (AD) risk communication to patients with mild cognitive impairment (MCI) and their visit companions. METHODS: Participants of the fourth REVEAL Study trial were randomized to receive AD risk assessments with or without g...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Patient Educ Couns
Egile Nagusiak: Guan, Yue, Roter, Debra L., Erby, Lori H., Wolff, Jennifer L., Gitlin, Laura N., Roberts, J. Scott, Green, Robert C., Christensen, Kurt D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5400683/
https://ncbi.nlm.nih.gov/pubmed/28012682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pec.2016.12.005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak